GLASSBORO Planning to offer certificates in various disciplines to both undergraduate and graduate students, Rowan University s new Institute for Cannabis Research, Policy, & Workforce Development aims to inform public health officials and create jobs under New Jersey s newly legalized recreational marijuana marketplace.
The timing of this launch was not at all coincidental, according to Dr. Anthony Lowman, Rowan provost and senior vice president of economic affairs.
Lowman said the greater Rowan region offers prime farmland for potential cannabis cultivation. We wanted to be ready when the state announced it, because this is a great opportunity, (and) South Jersey s in a great position, he said.
Posted on 378
ReGelTec, Inc., a medical device company developing a percutaneous treatment for chronic low back pain, announced today that it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA). The company’s leading product is HYDRAFIL™, a patented hydrogel that is heated prior to injection into the nucleus of a degenerated disc via a 17-gauge needle. When HYDRAFIL cools to body temperature it forms a contiguous implant within the nucleus to augment the disc, restore the biomechanical properties of that spinal segment, and alleviate pain.